Skip to content
Menu

Compass Therapeutics Q3 EPS $(0.15) Misses $(0.13) Estimate

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 87.5 percent decrease over losses of $(0.08) per share

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 87.5 percent decrease over losses of $(0.08) per share from the same period last year.

Read at benzinga.com